Early Prediction of Hypertensive Disorders of Pregnancy Using Cell-Free Fetal DNA, Cell-Free Total DNA, and Biochemical Markers

Publisher： Karger

E-ISSN： 1421-9964|40|4|255-262

ISSN： 1015-3837

Source： Fetal Diagnosis and Therapy, Vol.40, Iss.4, 2016-03, pp. : 255-262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Total and Fetal Cell-Free DNA Analysis in Maternal Blood as Markers of Placental Insufficiency in Intrauterine Growth Restriction

By  

Fetal Diagnosis and Therapy, Vol. 26, Iss. 1, 2009-10 ,pp. : 24-28

Karger

Access to resources Recommend Favorite

Maternal Plasma Cell-Free Fetal and Maternal DNA at 11-13 Weeks' Gestation: Relation to Fetal and Maternal Characteristics and Pregnancy Outcomes

By  

Fetal Diagnosis and Therapy, Vol. 33, Iss. 4, 2013-03 ,pp. : 215-223

Karger

Access to resources Recommend Favorite

Clinical Perspective of Cell-Free DNA Testing for Fetal Aneuploidies

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 3, 2014-06 ,pp. : 151-155

Karger

Access to resources Recommend Favorite

Fetal Fraction Estimate in Twin Pregnancies Using Directed Cell-Free DNA Analysis

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 3, 2013-12 ,pp. : 199-203

Karger

Access to resources Recommend Favorite

Assessment of Fetal Sex Chromosome Aneuploidy Using Directed Cell-Free DNA Analysis

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 1, 2013-12 ,pp. : 1-6

Karger

Access to resources Recommend Favorite